Brigham and Women's study finds daily multivitamins reduce risk of cancer in men
A daily multivitamin can help a man reduce his risk of cancer, according to new research from Brigham and Women's Hospital, a component of the Dana-Farber Cancer Institute. Researchers had nearly 15,000 men over the age of 50 take either a multivitamin or a placebo every day for more than 10 years. The men self-reported a cancer diagnosis, and researchers confirmed the diagnosis through medical records. Researchers found the group taking a daily multivitamin had an 8 percent reduction in total cancer compared with the group taking the placebo. They also found a multivitamin was associated with an apparent reduction in cancer deaths.
Among the research institutions NCI funds across the United States, it currently designates 67 as Cancer Centers. Largely based in research universities, these facilities are home to many of the NCI-supported scientists who conduct a wide range of intense, laboratory research into cancer’s origins and development. The Cancer Centers Program also focuses on trans-disciplinary research, including population science and clinical research. The centers’ research results are often at the forefront of studies in the cancer field.